$222 Million is the total value of INTERNATIONAL BIOTECHNOLOGY TRUST PLC's 49 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | New | CELGENE CORP | $21,042,000 | – | 181,722 | +100.0% | 9.48% | – |
| BIIB | New | BIOGEN INC | $18,693,000 | – | 65,908 | +100.0% | 8.42% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $16,375,000 | – | 133,841 | +100.0% | 7.38% | – |
| SHPG | New | SHIRE PLCsponsored adr | $16,220,000 | – | 95,200 | +100.0% | 7.31% | – |
| TSRO | New | TESARO INC | $12,705,000 | – | 94,500 | +100.0% | 5.72% | – |
| GILD | New | GILEAD SCIENCES INC | $12,590,000 | – | 175,784 | +100.0% | 5.67% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $11,910,000 | – | 32,430 | +100.0% | 5.36% | – |
| AMGN | New | AMGEN INC | $11,714,000 | – | 80,104 | +100.0% | 5.28% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $8,184,000 | – | 657,912 | +100.0% | 3.69% | – |
| INCY | New | INCYTE CORP | $7,898,000 | – | 78,775 | +100.0% | 3.56% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INC | $7,780,000 | – | 105,522 | +100.0% | 3.50% | – |
| ENTL | New | ENTELLUS MED INC | $7,631,000 | – | 403,320 | +100.0% | 3.44% | – |
| ILMN | New | ILLUMINA INC | $7,162,000 | – | 55,941 | +100.0% | 3.23% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $6,267,000 | – | 75,666 | +100.0% | 2.82% | – |
| AERI | New | AERIE PHARMACEUTICALS INC | $5,210,000 | – | 138,000 | +100.0% | 2.35% | – |
| CLVS | New | CLOVIS ONCOLOGY INC | $3,332,000 | – | 75,000 | +100.0% | 1.50% | – |
| ICPT | New | INTERCEPT PHARMACEUTICALS IN | $3,211,000 | – | 29,555 | +100.0% | 1.45% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $3,130,000 | – | 185,234 | +100.0% | 1.41% | – |
| LGND | New | LIGAND PHARMACEUTICALS INC | $3,048,000 | – | 30,000 | +100.0% | 1.37% | – |
| EXEL | New | EXELIXIS INC | $2,758,000 | – | 185,000 | +100.0% | 1.24% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $2,196,000 | – | 197,838 | +100.0% | 0.99% | – |
| KALV | New | KALVISTA PHARMACEUTICALS INC | $2,186,000 | – | 322,436 | +100.0% | 0.98% | – |
| VNDA | New | VANDA PHARMACEUTICALS INC | $2,166,000 | – | 135,817 | +100.0% | 0.98% | – |
| PRTA | New | PROTHENA CORP PLC | $2,066,000 | – | 42,000 | +100.0% | 0.93% | – |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $1,984,000 | – | 18,200 | +100.0% | 0.89% | – |
| SGYPQ | New | SYNERGY PHARMACEUTICALS DEL | $1,900,000 | – | 312,000 | +100.0% | 0.86% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $1,664,000 | – | 80,000 | +100.0% | 0.75% | – |
| KITE | New | KITE PHARMA INC | $1,637,000 | – | 36,500 | +100.0% | 0.74% | – |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $1,558,000 | – | 40,264 | +100.0% | 0.70% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $1,455,000 | – | 50,458 | +100.0% | 0.66% | – |
| New | NEURODERM LTD | $1,437,000 | – | 65,000 | +100.0% | 0.65% | – | |
| HZNP | New | HORIZON PHARMA PLC | $1,374,000 | – | 85,000 | +100.0% | 0.62% | – |
| DERM | New | DERMIRA INC | $1,364,000 | – | 45,000 | +100.0% | 0.61% | – |
| XNCR | New | XENCOR INC | $1,263,000 | – | 48,000 | +100.0% | 0.57% | – |
| New | TRILLIUM THERAPEUTICS INC | $1,253,000 | – | 221,847 | +100.0% | 0.56% | – | |
| TRXC | New | TRANSENTERIX INC | $1,156,000 | – | 889,082 | +100.0% | 0.52% | – |
| MGNX | New | MACROGENICS INC | $1,103,000 | – | 54,000 | +100.0% | 0.50% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $903,000 | – | 59,000 | +100.0% | 0.41% | – |
| SAGE | New | SAGE THERAPEUTICS INC | $867,000 | – | 16,996 | +100.0% | 0.39% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $838,000 | – | 7,500 | +100.0% | 0.38% | – |
| RDUS | New | RADIUS HEALTH INC | $753,000 | – | 19,799 | +100.0% | 0.34% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $736,000 | – | 60,000 | +100.0% | 0.33% | – |
| SRPT | New | SAREPTA THERAPEUTICS INC | $576,000 | – | 21,000 | +100.0% | 0.26% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $572,000 | – | 58,000 | +100.0% | 0.26% | – |
| ARRY | New | ARRAY BIOPHARMA INC | $571,000 | – | 65,000 | +100.0% | 0.26% | – |
| XLRN | New | ACCELERON PHARMA INC | $475,000 | – | 18,606 | +100.0% | 0.21% | – |
| ACOR | New | ACORDA THERAPEUTICS INC | $414,000 | – | 22,000 | +100.0% | 0.19% | – |
| ADAP | New | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $387,000 | – | 96,419 | +100.0% | 0.17% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $273,000 | – | 55,000 | +100.0% | 0.12% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-03-02
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC COMMO | 28 | Q3 2023 | 9.3% |
| INCYTE CORP INC COM | 28 | Q3 2023 | 7.9% |
| BIOMARIN PHARMACEUTICALS INC | 28 | Q3 2023 | 7.5% |
| REGENERON PHARMS. | 27 | Q3 2023 | 9.0% |
| BIOGEN INC COMMON STOCK | 26 | Q3 2023 | 8.7% |
| VERTEX PHARMS. | 25 | Q3 2023 | 8.4% |
| AMGEN INC COM | 25 | Q3 2023 | 7.9% |
| NEUROCRINE BIOSCIENCES INC | 25 | Q3 2023 | 6.9% |
| ALYNYLAM PHARMACEUTICALS INC | 25 | Q3 2023 | 6.7% |
| IONIS PHARMS. | 25 | Q3 2023 | 4.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Altus Pharmaceuticals Inc. | February 12, 2009 | ? | ? |
| MICROMET, INC. | February 14, 2008 | 1,907,390 | 4.7% |
| EPIMMUNE INC | February 15, 2005 | 1,279,659 | 8.0% |
| ESSENTIAL THERAPEUTICS INC | April 29, 2003 | 2,500,000 | 11.7% |
| TARGETED GENETICS CORP /WA/ | April 18, 2003 | ? | ? |
| ESSENTIAL THERAPEUTICS INC | November 05, 2001 | 11 | 13.0% |
| ONYX PHARMACEUTICALS INC | October 15, 2001 | 11 | 13.0% |
| CORVAS INTERNATIONAL INC | October 12, 2001 | 11 | 13.0% |
| RIBOZYME PHARMACEUTICALS INC | October 05, 2001 | 11 | 13.0% |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-18 |
| 13F-HR | 2023-02-01 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-20 |
| 13F-HR | 2022-02-15 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-11 |
View INTERNATIONAL BIOTECHNOLOGY TRUST PLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.